BioSpace News Archive

Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing

Eurofins Genomics U.S. announces that, together with its subsidiary BlueHeron Biotechnology, it has launched a series of SARS-CoV-2 plasmid DNA controls that can be used to verify the presence of the SARS-CoV-2 virus.

April 16, 2020
·
3 min read
Policy

Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA

Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA announced that Mayne Pharma has submitted a New Drug Application to the US Food and Drug Administration, seeking marketing authorisation for E4/DRSP, a combined oral contraceptive indicated for the prevention of pregnancy.

April 16, 2020
·
4 min read
Business

Cinclus Pharma Appoints Jenni Björnulfson as Chief Financial Officer

Cinclus Pharma Holding AB, which is developing a novel treatment for gastroesophageal reflux disease, announced the appointment of Jenni Björnulfson as Chief Financial Officer for the company.

April 16, 2020
·
4 min read
Business

Galapagos and Ryvu Announce Research Collaboration - April 16, 2020

Galapagos NV and Ryvu Therapeutics S.A. announced a collaboration focused on the discovery and development of novel small molecule drugs in inflammation.

April 16, 2020
·
6 min read
Business

Leading Global Antibody Discovery Companies FairJourney Biologics and Iontas Announce Partnership in Search for SARS-CoV-2 Treatment

Bringing together complementary services and technology to allow faster identification of effective antibodies with a higher chance of success in development

April 16, 2020
·
3 min read
Pharm Country

Umbilical Cord Blood Banking Market: Rapid Technological Advancement Favor Growth of the Market in Forthcoming Years

Umbilical cord blood or cord blood refers to the blood that stays inside the placenta and umbilical cord after delivery.

April 16, 2020
·
3 min read
Business

Elicio Therapeutics and National Cancer Institute Collaborate to Study ELI-002 Mutant KRAS Targeting Mechanism

Elicio Therapeutics, a next generation immuno-oncology company, announced that it has established a collaboration with the National Cancer Institute to characterize T cell responses to ELI-002 in animals.

April 16, 2020
·
3 min read
Business

Global Health Crisis Coordination Center Launches in Atlanta to Confront COVID-19 Outbreak

CDC Foundation and Microsoft provide seed funds for unprecedented private sector coordination effort to address health and safety threats

April 16, 2020
·
5 min read
Business

Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020

Agios Pharmaceuticals, Inc. announced that the company will host a conference call and live webcast on Thursday, April 30, 2020 at 8:00 a.m. ET to report its first quarter 2020 financial results and other business highlights.

April 16, 2020
·
1 min read
Business

Sage Therapeutics to Report First Quarter 2020 Financial Results on Thursday, May 7, 2020

Sage Therapeutics, Inc. announced it will host a live webcast on Thursday, May 7, 2020, at 4:30 p.m. EDT to announce first quarter 2020 financial results and discuss recent business updates..

April 16, 2020
·
1 min read